1188800

Diclofenacnatrium

United States Pharmacopeia (USP) Reference Standard

• Synonym(e): Diclofenac Natriumsalz, 2-[(2,6-Dichlorphenyl)-amino]-benzolessigsäure Natriumsalz
• Empirische Formel (Hill-System): C₁₄H₁₀Cl₂NNaO₂
• CAS-Nummer: 15307-79-6
• Molekulargewicht: 318.13
• MDL-Nummer: MFCD00082251
• UNSPSC-Code: 41116107
• PubChem Substanz-ID: 329749565
• NACRES: NA.24

Eigenschaften

• Qualität: pharmaceutical primary standard
• API-Familie: diclofenac
• Hersteller/Markenname: USP
• Anwendung(en): pharmaceutical (small molecule)
• Format: neat
• SMILES String: [Na+].[O-]C(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl
• InChI: 1S/C14H11Cl2NO2.Na/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19;/h1-7,17H,8H2,(H,18,19);/q;+1/p-1
• InChIKey: KPHWPUGNDIVLNH-UHFFFAOYSA-M
• Angaben zum Gen: human ... PTGS1(5742) , PTGS2(5743)

Beschreibung

Allgemeine Beschreibung

Diclofenac sodium is a sodium salt of diclofenac, a non-steroidal anti-inflammatory drug (NSAID). It prevents the synthesis of prostaglandin involved in pain, inflammation, and fever by inhibiting the cyclooxygenase enzyme activity.

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Anwendung

Diclofenac sodium USP reference standard suitable for use in specified USP compendial quality tests and assays.

Also used to prepare acid stage standard, standard, standard stock, sensitivity, and system suitability solution for the assay, impurity analysis, identification, and performance test by using liquid chromatography coupled with UV detector according to the given below monographs of United States Pharmacopeia (USP): 

• Diclofenac Sodium
• Diclofenac Sodium Delayed-Release Tablets  
• Diclofenac Sodium Extended-Release Tablets
• Diclofenac Sodium Topical Solution
• Diclofenac Sodium and Misoprostol Delayed-Release Tablets

Biochem./physiol. Wirkung

Standard NSAID und Cyclooxygenase (COX)-Hemmer. Hauptmetaboliten sind 4´-Hydroxydiclofenac und 5´-Hydroxydiclofenac. Für CYP2C9 selektives Substrat.

Hinweis zur Analyse

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Sonstige Hinweise

Sales restrictions may apply.

Sicherheitshinweise

• Piktogramme: GHS06,GHS08,GHS09
• Signalwort: Danger
• H-Sätze: H301,H361d,H372,H411
• P-Sätze: P202 - P260 - P264 - P270 - P273 - P301 + P310
• Gefahreneinstufungen: Acute Tox. 3 Oral - Aquatic Chronic 2 - Repr. 2 - STOT RE 1
• Lagerklassenschlüssel: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable